Aging is not a single event. It is the compounding failure of parallel biological systems: oxidative homeostasis collapses, immune tone drifts into chronic low-grade inflammation, metabolic flexibility narrows, gut barrier erodes, and neural circuitry loses plasticity. The scientific literature consolidates these converging failures under the hallmarks of aging, with inflammaging standing as the most tractable nutraceutical target. What Sabinsa has assembled over three decades of phytochemical and microbiome research is a multi-target longevity architecture: eight ingredients, each mechanistically grounded, collectively addressing every major aging hallmark from the gut lumen to the neuronal synapse.
Curcumin C3 Reduct® resolves curcumin's bioavailability paradox by delivering tetrahydrocurcuminoids (THCs), the reduced metabolites the body naturally generates from curcumin, directly and in their assimilable form. Independent research published in Aging demonstrated that THC extends lifespan in Drosophila melanogaster through the dFOXO/Sir2 sirtuin axis, the same pathway activated by caloric restriction, with Sir2-null mutants losing the effect entirely. EFSA-authorized at 140 mg/day and color-free, C3 Reduct® is the only reductive curcuminoid metabolite with EU Novel Food status.
Nigellin®, Sabinsa's supercritical CO2 extract of Nigella sativa standardized to 5% thymoquinone (TQ), addresses inflammaging at the immune-cellular interface. Independent reviews confirm TQ suppresses NF-κB and MAPK signaling, inhibits age-associated matrix metalloproteinases, restores mitochondrial antioxidant enzymes SOD and catalase, and activates autophagic flux. A 2024 RCT published in Medicine (Baltimore) validated a 41.5% reduction in nasal symptom scores and a significant IgE decline (p=0.03), confirming clinical-grade immune recalibration.
Silbinol® delivers pterostilbene from Pterocarpus marsupium, a more bioavailable and metabolically stable analog of resveratrol. Pterostilbene activates SIRT1, driving PGC-1α-mediated mitochondrial biogenesis and the mitochondrial unfolded protein response (UPRmt). In diabetic animal studies, Sabinsa-supplied pterostilbene outperformed resveratrol on blood glucose normalization, insulin restoration, and skeletal muscle contractile force recovery, directly addressing sarcopenia as a frailty driver.
Saberry®, standardized to 10% beta-glucogallin from Emblica officinalis, simultaneously inhibits alpha-glucosidase, alpha-amylase, and DPP-4. In a 90-day multicenter RCT (n=124), Saberry® at 2 g/day reduced fasting blood sugar by 21.8%, outperforming metformin, with significant concurrent reductions in HbA1c, LDL-C, and triglycerides.
Tinofolin®, derived from Tinospora cordifolia, modulates the HPA stress axis and improved verbal learning and logical memory in a placebo-controlled human study.
At the gut level, LactoSpore® (Bacillus coagulans MTCC 5856) delivers 92% spore survival through gastric conditions, downregulates IL-8, upregulates IL-10, enriches butyrate-producing microbiota, and demonstrated significant mood and IBS improvement in a gut-brain axis RCT (HAM-D score: 13.6 to 5.9 versus 14.5 to 12.5 in placebo; p=0.005). PoZibio® (heat-inactivated Lactobacillus paracasei D3.5) restores the gut mucosal barrier via lipoteichoic acid-driven mucin stimulation, targeting leaky gut as a root driver of systemic inflammaging. ImmunoSpore®, the postbiotic counterpart to LactoSpore® derived from heat-killed B. coagulans MTCC 5856, extends the same strain's barrier-protective and immunomodulatory signals into heat-processed formats without requiring live spore delivery.
Together, these eight ingredients form a systems-level longevity intervention: from sirtuin activation and immune recalibration to cardiometabolic control and gut barrier restoration, Sabinsa's portfolio offers a scientifically grounded, commercially actionable approach to the biology of aging itself.